Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Modified Frailty Index Predicts Postoperative Outcomes in Patients Undergoing Radical Pelvic Surgery.

McChesney SL, Canter DJ, Monlezun DJ, Green H, Margolin DA.

Am Surg. 2020 Feb 1;86(2):95-103.

PMID:
32167059
2.

Isolated adrenal metastectomy has a low morbidity rate irrespective of performing surgical sub-specialty.

Gurtner KE, May DN, Raman JD, Lata-Arias K, Canter DJ.

Can J Urol. 2019 Oct;26(5):9931-9937.

PMID:
31629442
3.

A randomized, controlled trial for transurethral treatment of bladder tumors using PlasmaButton vaporization electrode or monopolar loop electrocautery.

Alemozaffar M, Ogan K, Filson CP, Patil D, Lee G, Canter DJ, Hong G, Master VA.

Can J Urol. 2019 Oct;26(5):9908-9915.

PMID:
31629439
4.

Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.

Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ.

J Surg Oncol. 2019 Sep;120(4):753-760. doi: 10.1002/jso.25649. Epub 2019 Jul 29.

PMID:
31355444
5.

Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy.

Canter DJ, Freedland S, Rajamani S, Latsis M, Variano M, Halat S, Tward J, Cohen T, Stone S, Schlomm T, Bishoff J, Bardot S.

Prostate Cancer Prostatic Dis. 2020 Mar;23(1):102-107. doi: 10.1038/s41391-019-0159-9. Epub 2019 Jun 27.

6.

Accuracy of the NSQIP risk calculator for predicting complications following adrenalectomy.

Walker JB, Gogoj A, Saunders BD, Canter DJ, Lehman K, Raman JD.

Int Urol Nephrol. 2019 Aug;51(8):1291-1295. doi: 10.1007/s11255-019-02187-1. Epub 2019 Jun 10.

PMID:
31183661
7.

The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status.

Canter DJ, Nicholson S, Watkin N, Hall E, Pettaway C; InPACT Executive Committee.

Eur Urol Focus. 2019 Sep;5(5):706-709. doi: 10.1016/j.euf.2019.05.010. Epub 2019 Jun 1.

PMID:
31160252
8.

Ex-vivo donor partial nephrectomy at the time of donor-directed renal transplantation.

Wendel EC, Patel RD, Canter DJ.

Can J Urol. 2019 Apr;26(2):9740-9742.

PMID:
31012840
9.

EDITORIAL COMMENT.

May D, Canter DJ.

Urology. 2019 Mar;125:228-229. doi: 10.1016/j.urology.2018.11.022. No abstract available.

PMID:
30798970
10.

Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer.

Canter DJ, Reid J, Latsis M, Variano M, Halat S, Rajamani S, Gurtner KE, Sangale Z, Brawer M, Stone S, Bardot S.

Eur Urol. 2019 Mar;75(3):515-522. doi: 10.1016/j.eururo.2018.10.028. Epub 2018 Oct 31.

11.

Ileocalicostomy Ureteral Substitution for Complex Ureteropelvic Junction Stricture: Technique and Initial Experience.

Konheim JA, Khaled DT, Canter DJ.

Urology. 2018 Dec;122:174-178. doi: 10.1016/j.urology.2018.08.024. Epub 2018 Aug 29.

PMID:
30171917
12.

All negatives are not a negative.

Canter DJ.

Can J Urol. 2018 Aug;25(4):9413. No abstract available.

13.

Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery.

Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ.

J Surg Oncol. 2018 Mar;117(3):479-487. doi: 10.1002/jso.24866. Epub 2017 Oct 16.

14.

Intravesical rAd-IFN╬▒/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL 3rd, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN.

J Clin Oncol. 2017 Oct 20;35(30):3410-3416. doi: 10.1200/JCO.2017.72.3064. Epub 2017 Aug 23. Erratum in: J Clin Oncol. 2019 Aug 20;37(24):2187.

15.

The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections.

Park JS, Bateni SB, Bold RJ, Kirane AR, Canter DJ, Canter RJ.

J Surg Res. 2017 Sep;217:191-197. doi: 10.1016/j.jss.2017.05.025. Epub 2017 May 11.

16.

Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences.

Tazeh NN, Canter DJ, Damodaran S, Rushmer T, Richards KA, Abel EJ, Jarrard DF, Downs TM.

Bladder Cancer. 2017 Apr 27;3(2):89-94. doi: 10.3233/BLC-160085.

17.

A case report of a renal diffuse B-cell lymphoma.

Patel RD, Walker C, Canter DJ.

Can J Urol. 2017 Feb;24(1):8670-8672.

PMID:
28263135
18.

Pelvic Hardware Eroding Into the Bladder: A Rare Case Presentation of Gross Hematuria, Bladder Pain, and Refractory Lower Urinary Tract Symptoms.

Gurtner KE, Israel JA, Pinsky MR, Mautner JF, Miguez JB, Canter DJ.

Urology. 2017 Apr;102:e1-e2. doi: 10.1016/j.urology.2017.01.011. Epub 2017 Jan 16.

PMID:
28104419
19.

Unexpected High Rates of Angiography and Angioembolization for Isolated Low-grade Renal Trauma: Results From a Large, Statewide, Trauma Database.

Gor RA, Styskel BA, Li T, Canter DJ, Simhan J.

Urology. 2016 Nov;97:92-97. doi: 10.1016/j.urology.2016.05.042. Epub 2016 May 31.

PMID:
27261185
20.

Utility of Prostate Cancer Screening in Kidney Transplant Candidates.

Vitiello GA, Sayed BA, Wardenburg M, Perez SD, Keith CG, Canter DJ, Ogan K, Pearson TC, Turgeon N.

J Am Soc Nephrol. 2016 Jul;27(7):2157-63. doi: 10.1681/ASN.2014121182. Epub 2015 Dec 23.

21.

Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.

Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC.

Cancer Med. 2016 Feb;5(2):192-9. doi: 10.1002/cam4.577. Epub 2015 Dec 18.

22.

Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.

Fatima N, Canter DJ, Carthon BC, Kucuk O, Master VA, Nieh PT, Ogan K, Osunkoya AO.

Can J Urol. 2015 Jun;22(3):7783-7.

PMID:
26068625
23.

Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality.

Revenig LM, Canter DJ, Kim S, Liu Y, Sweeney JF, Sarmiento JM, Kooby DA, Maithel SK, Hill LL, Master VA, Ogan K.

J Am Coll Surg. 2015 May;220(5):904-11.e1. doi: 10.1016/j.jamcollsurg.2015.01.053. Epub 2015 Feb 25.

PMID:
25907870
25.
26.

Partial cystectomy for invasive bladder: the sirens' song?

Canter DJ.

Can J Urol. 2014 Dec;21(6):7528. No abstract available.

27.

Surgical Apgar Score predicts an increased risk of major complications and death after renal mass excision.

Ito T, Abbosh PH, Mehrazin R, Tomaszewski JJ, Li T, Ginzburg S, Canter DJ, Greenberg RE, Viterbo R, Chen DY, Kutikov A, Smaldone MC, Uzzo RG.

J Urol. 2015 Jun;193(6):1918-22. doi: 10.1016/j.juro.2014.11.085. Epub 2014 Nov 18.

PMID:
25464000
28.

Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.

Hsiao W, Herrel LA, Yu C, Kattan MW, Canter DJ, Carthon BC, Ogan K, Master VA.

Int J Urol. 2015 Mar;22(3):264-70. doi: 10.1111/iju.12672. Epub 2014 Nov 26.

29.

Preoperative quantification of perceptions of surgical frailty.

Revenig LM, Canter DJ, Henderson MA, Ogan K, Kooby DA, Maithel SK, Liu Y, Kim S, Master VA.

J Surg Res. 2015 Feb;193(2):583-9. doi: 10.1016/j.jss.2014.07.069. Epub 2014 Aug 6.

PMID:
25266605
30.

Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy.

Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Urology. 2014 Aug;84(2):351-7. doi: 10.1016/j.urology.2014.05.001. Epub 2014 Jun 26.

31.

Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy.

Tomaszewski JJ, Smaldone MC, Mehrazin R, Kocher N, Ito T, Abbosh P, Baber J, Kutikov A, Viterbo R, Chen DY, Canter DJ, Uzzo RG.

Urology. 2014 Aug;84(2):340-4. doi: 10.1016/j.urology.2014.04.013. Epub 2014 Jun 10.

32.

Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer.

Dobbs RW, Hugar LA, Revenig LM, Al-Qassab S, Petros JA, Ritenour CW, Issa MM, Canter DJ.

Int Braz J Urol. 2014 Mar-Apr;40(2):198-203. doi: 10.1590/S1677-5538.IBJU.2014.02.09.

33.

Re-examination of the natural history of high-grade T1 bladder cancer using a large contemporary cohort.

Canter DJ, Revenig LM, Smith ZL, Dobbs RW, Malkowicz SB, Issa MM, Guzzo TJ.

Int Braz J Urol. 2014 Mar-Apr;40(2):172-8. doi: 10.1590/S1677-5538.IBJU.2014.02.06.

34.

Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.

Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG.

J Urol. 2014 Sep;192(3):659-64. doi: 10.1016/j.juro.2014.03.038. Epub 2014 Mar 15.

35.

External validation of the modified Glasgow prognostic score for renal cancer.

Tai CG, Johnson TV, Abbasi A, Herrell L, Harris WB, Kucuk O, Canter DJ, Ogan K, Pattaras JG, Nieh PT, Master VA.

Indian J Urol. 2014 Jan;30(1):33-7. doi: 10.4103/0970-1591.124203.

36.

A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery.

Revenig LM, Canter DJ, Master VA, Maithel SK, Kooby DA, Pattaras JG, Tai C, Ogan K.

J Endourol. 2014 Apr;28(4):476-80. doi: 10.1089/end.2013.0496. Epub 2014 Jan 7.

PMID:
24308497
37.

Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.

Canter DJ, Mallin K, Uzzo RG, Egleston BL, Simhan J, Walton J, Smaldone MC, Master VA, Bratslavsky G, Kutikov A.

Can J Urol. 2013 Oct;20(5):6915-21.

PMID:
24128829
38.

Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes.

Revenig LM, Canter DJ, Taylor MD, Tai C, Sweeney JF, Sarmiento JM, Kooby DA, Maithel SK, Master VA, Ogan K.

J Am Coll Surg. 2013 Oct;217(4):665-670.e1. doi: 10.1016/j.jamcollsurg.2013.06.012.

PMID:
24054409
39.

Balancing disease and risk in octogenarians undergoing radical cystectomy.

Gor R, Canter DJ.

Can J Urol. 2013 Aug;20(4):6832. No abstract available.

40.

All men are created equal: benign prostatic hyperplasia, surgery, and politics.

Dobbs RW, Boorjian SA, Canter DJ.

Urology. 2013 Sep;82(3):508-10. doi: 10.1016/j.urology.2013.05.003. Epub 2013 Jul 4. No abstract available.

PMID:
23831072
41.
42.

Therapeutic options for a rising PSA after radical prostatectomy.

Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ.

Can J Urol. 2013 Jun;20(3):6748-55. Review.

43.
44.

Is simpler better? Quality of life based on type of urinary diversion.

Canter DJ.

Can J Urol. 2013 Feb;20(1):6632. No abstract available.

45.

Salvage therapy for locally recurrent prostate cancer after radiation.

Marcus DM, Canter DJ, Jani AB, Dobbs RW, Schuster DM, Carthon BC, Rossi PJ.

Can J Urol. 2012 Dec;19(6):6534-41. Review.

PMID:
23228288
46.

Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.

Simhan J, Canter DJ, Sterious SN, Smaldone MC, Tsai KJ, Li T, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Uzzo RG.

J Urol. 2013 Jan;189(1):43-7. doi: 10.1016/j.juro.2012.08.092. Epub 2012 Nov 16.

PMID:
23164383
47.

A rare case of solitary metastatic non-seminomatous malignant germ cell tumor to the prostate.

Dobbs RW, Osunkoya AO, Nieh PT, Canter DJ.

Can J Urol. 2012 Oct;19(5):6471-3.

PMID:
23040630
48.

Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.

Long CJ, Canter DJ, Smaldone MC, Li T, Simhan J, Rozenfeld B, Teper E, Chen DY, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A.

Can J Urol. 2012 Oct;19(5):6417-22. Review.

49.

Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer.

Herrel LA, Canter DJ.

BJU Int. 2013 Apr;111(4 Pt B):E173. doi: 10.1111/j.1464-410X.2012.11511.x. Epub 2012 Oct 4. No abstract available.

50.

The effect of 5-aminolevulinic acid and its derivatives on protoporphyrin IX accumulation and apoptotic cell death in castrate-resistant prostate cancer cells.

Teper E, Makhov P, Golovine K, Canter DJ, Myers CB, Kutikov A, Sterious SN, Uzzo RG, Kolenko VM.

Urology. 2012 Dec;80(6):1391.e1-7. doi: 10.1016/j.urology.2012.07.008. Epub 2012 Aug 28.

Supplemental Content

Loading ...
Support Center